Musaffa Logo
H World Group Ltd HWLDF
$3.73

Last Updated: Aug 06, 12:00 AM·OOTC

Pricing for US stocks is delayed by 24 hours

HWLDF Shariah Compliance

Screening Methodology: AAOIFI

As of August 2026, H World Group Ltd is classified as doubtful.

DOUBTFUL

Report Source: undefined Quarter Report

H World Group Ltd

H World Group Ltd. Stock Analysis HWLDF

United States Consumer Discretionary Large Cap

H World Group Ltd (HWLDF) Chart

Financial Metrics & Statements of H World Group Ltd (HWLDF)

FAQ's for H World Group Ltd (HWLDF)

  • As of August 2026, H World Group Ltd HWLDF is classified as doubtful according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
  • A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes H World Group Ltd using these criteria to determine its compliance status.
  • Muslim investors may consider investing in H World Group Ltd if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
  • Musaffa determines the Shariah status of H World Group Ltd by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
  • The Shariah compliance status of H World Group Ltd may be updated periodically when new financial statements, earnings reports, or business activity information become available.
  • Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
  • You can check the latest Shariah compliance status of H World Group Ltd on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.